What is the recommended dose of Bactrim (trimethoprim/sulfamethoxazole) DS for treating a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Bactrim DS for UTI Treatment

The recommended dosage of Bactrim DS (trimethoprim-sulfamethoxazole) for treating a urinary tract infection is one double-strength tablet (160 mg trimethoprim/800 mg sulfamethoxazole) taken orally every 12 hours for 10-14 days for uncomplicated UTIs, with a longer 14-day course specifically recommended for pyelonephritis. 1, 2

Dosing Guidelines by UTI Type

Uncomplicated Cystitis (Lower UTI)

  • For uncomplicated cystitis in adults, the standard dose is one Bactrim DS tablet (160/800 mg) every 12 hours for 3 days 1, 3
  • In regions with known low resistance rates, a shorter 3-day course may be sufficient for uncomplicated lower UTIs 3, 4
  • If local resistance patterns are unknown or high (>20%), consider alternative first-line agents such as nitrofurantoin or fosfomycin 1, 3

Pyelonephritis (Upper UTI)

  • For pyelonephritis, one Bactrim DS tablet (160/800 mg) every 12 hours for 14 days is recommended 1, 2
  • If using Bactrim when susceptibility is unknown, an initial intravenous dose of a long-acting parenteral antimicrobial (such as 1g ceftriaxone) should be administered before starting oral Bactrim 1
  • Bactrim should only be used for pyelonephritis if the uropathogen is known to be susceptible 1

Special Considerations

Resistance Patterns

  • Local resistance patterns should guide therapy selection; Bactrim should not be used empirically in areas where E. coli resistance exceeds 20% 1, 3
  • If resistance is suspected or confirmed, fluoroquinolones or cephalosporins may be more appropriate alternatives 1
  • Always obtain urine culture and susceptibility testing in cases of pyelonephritis, recurrent UTI, or treatment failure 1

Dosing in Renal Impairment

  • For patients with creatinine clearance 15-30 mL/min: reduce dose to half the usual regimen 2
  • For patients with creatinine clearance <15 mL/min: Bactrim is not recommended 2

Treatment Duration Considerations

  • While shorter courses (3 days) may be effective for uncomplicated cystitis in women, longer courses are associated with lower early recurrence rates 5, 4
  • Men with UTI generally require longer treatment durations (7-14 days) compared to women with uncomplicated UTI 1, 3

Efficacy and Alternatives

  • Bactrim has similar efficacy to fluoroquinolones for uncomplicated UTIs but with fewer adverse effects 6
  • Fluoroquinolones should be reserved for more invasive infections due to concerns about collateral damage and resistance 1, 3
  • Nitrofurantoin and fosfomycin are appropriate first-line alternatives for uncomplicated cystitis but should not be used for pyelonephritis 1, 3

Common Pitfalls to Avoid

  • Avoid using Bactrim empirically in areas with high resistance rates (>20%) 1, 3
  • Do not use Bactrim in patients with severe renal impairment (CrCl <15 mL/min) 2
  • Never use Bactrim in children under 2 months of age 2
  • Avoid underdosing or shortening therapy duration for pyelonephritis, as this can lead to treatment failure and recurrence 1
  • Remember that Bactrim should only be used for pyelonephritis when the pathogen is known to be susceptible 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.